Discontinued — last reported Q4 '25
Bank of New York Mellon Interest Paid decreased by 13.6% to $4.36B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.2%, from $4.91B to $4.36B. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 206.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $19.00M | $81.00M | $7.00M | $107.00M | $267.00M | $981.00M | $1.95B | $2.67B | $4.02B | $4.51B | $4.83B | $4.96B | $5.42B | $5.61B | $5.38B | $4.91B | $5.36B | $5.31B | $5.05B | $4.36B |
| QoQ Change | — | +326.3% | -91.4% | >999% | +149.5% | +267.4% | +99.0% | +36.8% | +50.5% | +12.1% | +7.1% | +2.7% | +9.4% | +3.6% | -4.1% | -8.7% | +9.1% | -1.0% | -4.9% | -13.6% |
| YoY Change | — | — | — | — | >999% | >999% | >999% | >999% | >999% | +359.2% | +147.2% | +85.5% | +34.9% | +24.6% | +11.6% | -0.8% | -1.1% | -5.5% | -6.3% | -11.2% |